{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T10:32:05Z","timestamp":1778409125475,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/cad.0b013e32835739dd","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T11:56:23Z","timestamp":1343994983000},"page":"1054-1066","source":"Crossref","is-referenced-by-count":46,"title":["Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma"],"prefix":"10.1097","volume":"23","author":[{"given":"Song","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Chlenski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen R.","family":"Salwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Usha","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210227","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"Classification system: an INRG task force report.","volume":"27","author":"Cohn","year":"2009","journal-title":"J Clin Oncol"},{"key":"R2-7-20210227","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"Staging system: an INRG task force report.","volume":"27","author":"Tom","year":"2009","journal-title":"J Clin Oncol"},{"key":"R3-7-20210227","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/0008-5472.828.65.3","article-title":"CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas.","volume":"65","author":"Abe","year":"2005","journal-title":"Cancer Res"},{"key":"R4-7-20210227","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1158\/0008-5472.CAN-04-0956","article-title":"Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.","volume":"64","author":"Yang","year":"2004","journal-title":"Cancer Res"},{"key":"R5-7-20210227","first-page":"6299","article-title":"Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.","volume":"63","author":"Yang","year":"2003","journal-title":"Cancer Res"},{"key":"R6-7-20210227","doi-asserted-by":"crossref","first-page":"e23127","DOI":"10.1371\/journal.pone.0023127","article-title":"Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.","volume":"6","author":"Mossman","year":"2011","journal-title":"PLoS One"},{"key":"R7-7-20210227","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2174\/092986711795496791","article-title":"Epigenetically-targeted therapies for the treatment of hematological malignancies.","volume":"18","author":"Georgiou","year":"2011","journal-title":"Curr Med Chem"},{"key":"R8-7-20210227","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2407-10-286","article-title":"Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.","volume":"10","author":"Yang","year":"2010","journal-title":"BMC Cancer"},{"key":"R9-7-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/11316270-000000000-00000","article-title":"A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.","volume":"12","author":"Bidabadi","year":"2010","journal-title":"Paediatr Drugs"},{"key":"R10-7-20210227","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/17425251003693547","article-title":"Valproate semisodium ER for migraine and cluster headache prophylaxis.","volume":"6","author":"Lovell","year":"2010","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"R11-7-20210227","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M109.057836","article-title":"Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the Alzheimer amyloid precursor protein.","volume":"285","author":"Venkataramani","year":"2010","journal-title":"J Biol Chem"},{"key":"R12-7-20210227","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1158\/0008-5472.CAN-06-2595","article-title":"Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res"},{"key":"R13-7-20210227","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/00001813-199609000-00008","article-title":"Antitumor activity of sodium valproate in cultures of human neuroblastoma cells.","volume":"7","author":"Cinatl","year":"1996","journal-title":"Anticancer Drugs"},{"key":"R14-7-20210227","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1158\/1078-0432.CCR-06-2846","article-title":"Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.","volume":"13","author":"Yang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R15-7-20210227","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2009.02.064","article-title":"N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.","volume":"1268","author":"Janardhanan","year":"2009","journal-title":"Brain Res"},{"key":"R16-7-20210227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-0500-1-54","article-title":"A new approach to primer design for the control of PCR bias in methylation studies.","volume":"1","author":"Wojdacz","year":"2008","journal-title":"BMC Res Notes"},{"key":"R17-7-20210227","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4161\/epi.9020","article-title":"Primer design versus PCR bias in methylation independent PCR amplifications.","volume":"4","author":"Wojdacz","year":"2009","journal-title":"Epigenetics"},{"key":"R18-7-20210227","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1158\/0008-5472.CAN-10-0847","article-title":"DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.","volume":"70","author":"Shah","year":"2010","journal-title":"Cancer Res"},{"key":"R19-7-20210227","doi-asserted-by":"crossref","first-page":"8493","DOI":"10.1158\/1078-0432.CCR-04-1331","article-title":"Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.","volume":"10","author":"Yang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R20-7-20210227","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1371\/journal.pmed.0050114","article-title":"Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis.","volume":"5","author":"Chan","year":"2008","journal-title":"PLoS Med"},{"key":"R21-7-20210227","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2407-10-23","article-title":"Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.","volume":"10","author":"Ramos","year":"2010","journal-title":"BMC Cancer"},{"key":"R22-7-20210227","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/138161209787315774","article-title":"Targeting histone deacetylases in neuroblastoma.","volume":"15","author":"Witt","year":"2009","journal-title":"Curr Pharm Des"},{"key":"R23-7-20210227","first-page":"1795","article-title":"Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo.","volume":"25","author":"Michaelis","year":"2004","journal-title":"Int J Oncol"},{"key":"R25-7-20210227","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1073\/pnas.1018091108","article-title":"Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor.","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R26-7-20210227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-230X-10-91","article-title":"Constitutive activation of glycogen synthase kinase-3beta correlates with better prognosis and cyclin-dependent kinase inhibitors in human gastric cancer.","volume":"10","author":"Cho","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"R27-7-20210227","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1038\/sj.onc.1207158","article-title":"Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.","volume":"22","author":"Agarwal","year":"2003","journal-title":"Oncogene"},{"key":"R28-7-20210227","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bcp.2008.12.002","article-title":"The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.","volume":"77","author":"Cabello","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"R29-7-20210227","first-page":"6504","article-title":"Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.","volume":"54","author":"Weinstat-Saslow","year":"1994","journal-title":"Cancer Res"},{"key":"R30-7-20210227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.phrs.2010.10.014","article-title":"Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.","volume":"63","author":"Yao","year":"2011","journal-title":"Pharmacol Res"},{"key":"R31-7-20210227","first-page":"7357","article-title":"SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.","volume":"62","author":"Chlenski","year":"2002","journal-title":"Cancer Res"},{"key":"R32-7-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/75007","article-title":"Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.","volume":"6","author":"Teitz","year":"2000","journal-title":"Nat Med"},{"key":"R33-7-20210227","first-page":"111","article-title":"Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.","volume":"39","author":"Fortson","year":"2011","journal-title":"Int J Oncol"},{"key":"R35-7-20210227","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1038\/onc.2010.12","article-title":"A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.","volume":"29","author":"Zhang","year":"2010","journal-title":"Oncogene"},{"key":"R36-7-20210227","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1158\/0008-5472.CAN-05-1663","article-title":"HIN-1, an inhibitor of cell growth, invasion, and AKT activation.","volume":"65","author":"Krop","year":"2005","journal-title":"Cancer Res"},{"key":"R37-7-20210227","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/316160a0","article-title":"Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture.","volume":"316","author":"Schwab","year":"1985","journal-title":"Nature"},{"key":"R38-7-20210227","first-page":"171","article-title":"The biological effects of antisense N-myc expression in human neuroblastoma.","volume":"5","author":"Schmidt","year":"1994","journal-title":"Cell Growth Differ"},{"key":"R39-7-20210227","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/313404a0","article-title":"Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma.","volume":"313","author":"Thiele","year":"1985","journal-title":"Nature"},{"key":"R40-7-20210227","first-page":"457","article-title":"Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.","volume":"12","author":"Peverali","year":"1996","journal-title":"Oncogene"},{"key":"R41-7-20210227","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/hmg\/ddi028","article-title":"Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer.","volume":"14","author":"Frigola","year":"2005","journal-title":"Hum Mol Genet"},{"key":"R42-7-20210227","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","article-title":"Epigenetics in cancer.","volume":"358","author":"Esteller","year":"2008","journal-title":"N Engl J Med"},{"key":"R43-7-20210227","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature05918","article-title":"Stability and flexibility of epigenetic gene regulation in mammalian development.","volume":"447","author":"Reik","year":"2007","journal-title":"Nature"},{"key":"R44-7-20210227","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1073\/pnas.0700529104","article-title":"Histone hyperacetylation induces demethylation of reelin and 67 kDa glutamic acid decarboxylase promoters.","volume":"104","author":"Dong","year":"2007","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e32835739dd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T03:43:48Z","timestamp":1687664628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201211000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32835739dd","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}